Logo image of Z

ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:Z - US98954M2008 - Common Stock

75.52 USD
-0.49 (-0.64%)
Last: 12/4/2025, 8:00:03 PM
75.29 USD
-0.23 (-0.3%)
After Hours: 12/4/2025, 8:00:03 PM
Fundamental Rating

5

Taking everything into account, Z scores 5 out of 10 in our fundamental rating. Z was compared to 64 industry peers in the Real Estate Management & Development industry. No worries on liquidiy or solvency for Z as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, Z is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year Z was profitable.
Z had a positive operating cash flow in the past year.
Z had negative earnings in each of the past 5 years.
Of the past 5 years Z 4 years had a positive operating cash flow.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

Z has a Return On Assets of -0.56%. This is comparable to the rest of the industry: Z outperforms 46.88% of its industry peers.
The Return On Equity of Z (-0.64%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.56%
ROE -0.64%
ROIC N/A
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

The Gross Margin of Z (74.87%) is better than 89.06% of its industry peers.
Z's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, Z has more shares outstanding
The number of shares outstanding for Z has been increased compared to 5 years ago.
Z has a better debt/assets ratio than last year.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Z has an Altman-Z score of 15.89. This indicates that Z is financially healthy and has little risk of bankruptcy at the moment.
Z has a Altman-Z score of 15.89. This is amongst the best in the industry. Z outperforms 95.31% of its industry peers.
Z has a debt to FCF ratio of 1.83. This is a very positive value and a sign of high solvency as it would only need 1.83 years to pay back of all of its debts.
Z has a Debt to FCF ratio of 1.83. This is amongst the best in the industry. Z outperforms 84.38% of its industry peers.
Z has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.05, Z is doing good in the industry, outperforming 79.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.83
Altman-Z 15.89
ROIC/WACCN/A
WACC8.34%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

Z has a Current Ratio of 3.63. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
Z has a Current ratio of 3.63. This is amongst the best in the industry. Z outperforms 81.25% of its industry peers.
Z has a Quick Ratio of 3.63. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
Z has a Quick ratio of 3.63. This is amongst the best in the industry. Z outperforms 84.38% of its industry peers.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 3.63
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

Z shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.92%, which is quite good.
Looking at the last year, Z shows a quite strong growth in Revenue. The Revenue has grown by 15.17% in the last year.
Measured over the past years, Z shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)16.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
Revenue 1Y (TTM)15.17%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.35%

3.2 Future

Z is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.58% yearly.
The Revenue is expected to grow by 14.16% on average over the next years. This is quite good.
EPS Next Y22.85%
EPS Next 2Y27.79%
EPS Next 3Y29.97%
EPS Next 5Y30.58%
Revenue Next Year15.76%
Revenue Next 2Y14.95%
Revenue Next 3Y14.6%
Revenue Next 5Y14.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 49.68, which means the current valuation is very expensive for Z.
Based on the Price/Earnings ratio, Z is valued a bit cheaper than 65.63% of the companies in the same industry.
Z's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.41.
Based on the Price/Forward Earnings ratio of 33.75, the valuation of Z can be described as expensive.
75.00% of the companies in the same industry are more expensive than Z, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of Z to the average of the S&P500 Index (35.40), we can say Z is valued inline with the index average.
Industry RankSector Rank
PE 49.68
Fwd PE 33.75
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of Z is on the same level as its industry peers.
62.50% of the companies in the same industry are more expensive than Z, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 122.68
EV/EBITDA 95.34
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates Z does not grow enough to justify the current Price/Earnings ratio.
Z's earnings are expected to grow with 29.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.17
PEG (5Y)N/A
EPS Next 2Y27.79%
EPS Next 3Y29.97%

0

5. Dividend

5.1 Amount

No dividends for Z!.
Industry RankSector Rank
Dividend Yield N/A

ZILLOW GROUP INC - C

NASDAQ:Z (12/4/2025, 8:00:03 PM)

After market: 75.29 -0.23 (-0.3%)

75.52

-0.49 (-0.64%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-09 2026-02-09/amc
Inst Owners95.68%
Inst Owner Change3.88%
Ins Owners6.45%
Ins Owner Change-5.9%
Market Cap18.28B
Revenue(TTM)2.48B
Net Income(TTM)-32.00M
Analysts74.19
Price Target88.74 (17.51%)
Short Float %8.19%
Short Ratio4.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.54%
Min EPS beat(2)-7.26%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-1.47%
Min EPS beat(4)-7.26%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)15.83%
EPS beat(12)10
Avg EPS beat(12)58.09%
EPS beat(16)14
Avg EPS beat(16)70.28%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.18%
Max Revenue beat(2)-0.78%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)-0.3%
Revenue beat(8)4
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)2.19%
Revenue beat(16)10
Avg Revenue beat(16)-4.77%
PT rev (1m)-1.72%
PT rev (3m)-1.84%
EPS NQ rev (1m)3.4%
EPS NQ rev (3m)3.27%
EPS NY rev (1m)1.08%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE 49.68
Fwd PE 33.75
P/S 7.36
P/FCF 122.68
P/OCF 43.73
P/B 3.66
P/tB 9.64
EV/EBITDA 95.34
EPS(TTM)1.52
EY2.01%
EPS(NY)2.24
Fwd EY2.96%
FCF(TTM)0.62
FCFY0.82%
OCF(TTM)1.73
OCFY2.29%
SpS10.26
BVpS20.62
TBVpS7.83
PEG (NY)2.17
PEG (5Y)N/A
Graham Number26.56
Profitability
Industry RankSector Rank
ROA -0.56%
ROE -0.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.87%
FCFM 6%
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.83
Debt/EBITDA 1.57
Cap/Depr 102.28%
Cap/Sales 10.83%
Interest Coverage N/A
Cash Conversion 241.62%
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 3.63
Altman-Z 15.89
F-Score7
WACC8.34%
ROIC/WACCN/A
Cap/Depr(3y)73.5%
Cap/Depr(5y)73.95%
Cap/Sales(3y)7.76%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
EPS Next Y22.85%
EPS Next 2Y27.79%
EPS Next 3Y29.97%
EPS Next 5Y30.58%
Revenue 1Y (TTM)15.17%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.35%
Revenue Next Year15.76%
Revenue Next 2Y14.95%
Revenue Next 3Y14.6%
Revenue Next 5Y14.16%
EBIT growth 1Y57.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year428.57%
EBIT Next 3Y95.63%
EBIT Next 5Y58.6%
FCF growth 1Y-21.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.75%
OCF growth 3YN/A
OCF growth 5YN/A

ZILLOW GROUP INC - C / Z FAQ

What is the ChartMill fundamental rating of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a fundamental rating of 5 / 10 to Z.


What is the valuation status for Z stock?

ChartMill assigns a valuation rating of 3 / 10 to ZILLOW GROUP INC - C (Z). This can be considered as Overvalued.


How profitable is ZILLOW GROUP INC - C (Z) stock?

ZILLOW GROUP INC - C (Z) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ZILLOW GROUP INC - C (Z) stock?

The Price/Earnings (PE) ratio for ZILLOW GROUP INC - C (Z) is 49.68 and the Price/Book (PB) ratio is 3.66.


Can you provide the expected EPS growth for Z stock?

The Earnings per Share (EPS) of ZILLOW GROUP INC - C (Z) is expected to grow by 22.85% in the next year.